Noruega - noruego - Statens legemiddelverk

rotop pharmaka gmbh - albumin, humant, nanokolloidale partikler - preparasjonssett til radioaktive legemidler - 0.5 mg

Noruega - noruego - Statens legemiddelverk

laboratoires thea s.a.s - tropikamid / fenylefrinhydroklorid / lidokainhydrokloridmonohydrat - injeksjonsvæske, oppløsning - 0.2 mg/ ml / 3.1 mg/ ml / 10 mg/ ml

Unión Europea - noruego - EMA (European Medicines Agency)

le vet b.v. - prednisolon - kortikosteroider til systemisk bruk, vanlig, prednisolon, systemic hormonal preparations, ekskl. sex hormoner og insulin - hester - lindring av inflammatoriske og kliniske parametere assosiert med tilbakevendende luftveisobstruksjon (rao) hos hester, i kombinasjon med miljøkontroll.

Unión Europea - noruego - EMA (European Medicines Agency)

swedish orphan biovitrum ab (publ) - anakinra - arthritis, rheumatoid; covid-19 virus infection - immunsuppressive - rheumatoid arthritis (ra)kineret is indicated in adults for the treatment of the signs and symptoms of ra in combination with methotrexate, with an inadequate response to methotrexate alone. covid-19kineret is indicated for the treatment of coronavirus disease 2019 (covid-19) in adult patients with pneumonia requiring supplemental oxygen (low- or high-flow oxygen) who are at risk of progressing to severe respiratory failure determined by plasma concentration of soluble urokinase plasminogen activator receptor (supar) ≥ 6 ng/ml. periodic fever syndromeskineret is indicated for the treatment of the following autoinflammatory periodic fever syndromes in adults, adolescents, children and infants aged 8 months and older with a body weight of 10 kg or above:cryopyrin-associated periodic syndromes (caps)kineret is indicated for the treatment of caps, including:neonatal-onset multisystem inflammatory disease (nomid) / chronic infantile neurological, cutaneous, articular syndrome (cinca)muckle-wells syndrome (mws)familial cold autoinflammatory syndrome (fcas)familial mediterranean fever (fmf)kineret is indicated for the treatment of familial mediterranean fever (fmf). kineret bør gis i kombinasjon med colchicine, hvis det er aktuelt. still’s diseasekineret is indicated in adults, adolescents, children and infants aged 8 months and older with a body weight of 10 kg or above for the treatment of still’s disease, including systemic juvenile idiopathic arthritis (sjia) and adult-onset still’s disease (aosd), with active systemic features of moderate to high disease activity, or in patients with continued disease activity after treatment with non-steroidal anti-inflammatory drugs (nsaids) or glucocorticoids. kineret can be given as monotherapy or in combination with other anti-inflammatory drugs and disease-modifying antirheumatic drugs (dmards).

Unión Europea - noruego - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a. - diphtheria toxoid, hepatitis b surface antigen, bordetella pertussis (inactivated), tetanus toxoid - hepatitis b; tetanus; immunization; whooping cough; diphtheria - vaksiner - tritanrix hepb er indisert for aktiv immunisering mot difteri, tetanus, pertussis og hepatitt b (hbv) hos spedbarn fra seks uker og fremover (se avsnitt 4.

Noruega - noruego - Statens legemiddelverk

eli lilly norge as - insulin - injeksjonsvæske, suspensjon - 100 ie/ ml

Noruega - noruego - Statens legemiddelverk

fresenius kabi norge as - halden - soyaolje, renset - infusjonsvæske, emulsjon - 200 mg/ ml

Noruega - noruego - Statens legemiddelverk

abbvie as - leuprorelinacetat - pulver og væske til injeksjonsvæske, suspensjon i tokammersprøyte - 11.25 mg

Noruega - noruego - Statens legemiddelverk

abbvie as - leuprorelinacetat - pulver og væske til injeksjonsvæske, suspensjon i tokammersprøyte - 3.75 mg

Noruega - noruego - Statens legemiddelverk

abbvie as - leuprorelinacetat - pulver og væske til injeksjonsvæske, suspensjon i tokammersprøyte - 30 mg